Evidence map›Paper›PMID 41357623›Full record

ReviewWorld journal of gastrointestinal surgery2025

Application status of endoscopic anti-reflux mucosal interventions in the treatment of gastroesophageal reflux disease.

Ze-Hua Zhang, Shuang-Zhu Yang, Jing-Jing Lian, Ai-Ping Xu, Xiao-Jing Du, Tao Chen, Mei-Dong Xu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of gastrointestinal surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ze-Hua ZhangEndoscopy Center, Department of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Shuang-Zhu YangEndoscopy Center, Department of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Jing-Jing LianEndoscopy Center, Department of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Ai-Ping XuEndoscopy Center, Department of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Xiao-Jing DuEndoscopy Center, Department of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Tao ChenEndoscopy Center, Department of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Mei-Dong XuEndoscopy Center, Department of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China. 1800512@tongji.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prevalence of gastroesophageal reflux disease (GERD) has shown an upward trend over the years. Even though patients with GERD have a poor quality of life, the current treatment options are highly limited. In recent years, however, the development of anti-reflux mucosal intervention (ARMI), a novel strategy for treating GERD, has provided hope to such patients. ARMI comprises three main steps: Anti-reflux mucosectomy, anti-reflux mucosal ablation, and peroral endoscopic cardial constriction. ARMI involves the constriction of the pericardial mucosa through endoscopic surgery so as to reduce the damage caused by the reflux of gastric contents. This study compares different ARMI techniques, their therapeutic efficacy in treating GERD, indications and contraindications, endoscopic operational procedures, perioperative management, and adverse events, in an attempt to provide clinical guidance.

Indexed as

Anti-reflux mucosal ablationAnti-reflux mucosal interventionAnti-reflux mucosectomyGastroesophageal reflux diseasePeroral endoscopic cardial constrictionPostoperative adverse reactionSurgical contraindications

Identifiers

PMID41357623
PMCPMC12678975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.